ANNA GRACE BARNES: Open Payments
NPI 1659950285 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,731 in 82 payments from 30 companies in 2025. Trend: 2023 $849 · 2024 $972 · 2025 $1,731
Food & beverage: $1,632Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $229 |
| Novartis Pharmaceuticals Corporation | 9 | $196 |
| Celgene Corporation | 6 | $144 |
| PFIZER INC. | 8 | $135 |
| BeOne Medicines USA, Inc. | 7 | $128 |
| SEAGEN INC. | 1 | $99 |
| E.R. Squibb & Sons, L.L.C. | 5 | $92 |
| Blueprint Medicines Corporation | 3 | $77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $70 |
| Merck Sharp & Dohme LLC | 3 | $67 |
Products named: IMFINZI, REBLOZYL, BRUKINSA, OPDIVO, PLUVICTO, AYVAKIT, KISQALI, KEYTRUDA.
Industry payments across AL — which companies pay providers there.
